Altran Technologies : There is still some upside potential
Entry price | Target | Stop-loss | Potential |
---|
€0 |
€15 |
€12.67 |
+∞% |
---|
Shares in Altran Technologies show a positive technical chart pattern over the medium term, which suggests that the rising trend should be followed.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 11.67 EUR
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at EUR 13.43.
● Technically, the stock approaches a strong medium-term resistance at EUR 13.56.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.